DSM Pharmaceutical Products today announced that they will join the Green
Chemistry Institute® Pharmaceutical Roundtable (Roundtable) of the American
Chemical Society (ACS) as an associate member. The Pharmaceutical Roundtable
is a partnership between the ACS Green Chemistry Institute® and pharmaceutical
companies. The roundtable was founded in 2005 to promote sustainable
manufacturing of active pharmaceutical ingredients (APIs) by integrating the
principles of green chemistry and engineering into drug discovery and
manufacturing. Recently it was decided that companies which are significantly
engaged in research and development or manufacturing of intermediates and APIs
for the pharmaceutical industry could apply for membership. DSM
Pharmaceutical Products is the first such company to join the Roundtable.
Bob Hartmayer, president & CEO of the DSM Pharmaceutical Products business
group, commented, “I am proud that DSM’s ambition to play in the top league of
sustainable manufacturers is recognized by the Roundtable members. It
stimulates us to continue to work with our customers towards new and green
synthetic routes for API synthesis; to be the first supplier company to join
this roundtable is a real honor”.
Bob Peoples, director of the ACS Green Chemistry Institute®, comments: “The
addition of DSM as our first associate member is a significant development in
the expansion of the ACS GCI Pharmaceutical Roundtable. We look forward to
working with DSM who brings complementary expertise to support the mission of
the Roundtable and will further leverage the excellent work of this dedicated
group of leading pharmaceutical companies.”
DSM Pharmaceutical Products
DSM Pharmaceutical Products is a
global provider of high quality custom contract manufacturing and development
services to the pharmaceutical and biopharmaceutical industries. DSM contract
manufacturing services include: chemical development, registered
intermediates, registered starting materials, active pharmaceutical
ingredients (API's), fermentation, mammalian cell production of monoclonal
antibodies and proteins, formulation development, clinical trial manufacturing
and finished dose form manufacturing of solids, semi-solids, and scheduled
drugs, aseptic liquid and lyophilized products. More information:
www.dsmpharmaceuticals.com
DSM Pharma Chemicals
DSM Pharma Chemicals is a global provider
of custom manufacturing services to the pharmaceutical industry. Including
advanced intermediates, registered materials and active pharmaceutical
ingredients. Our technologies include biocatalysis, homogeneous catalysis,
fermentation and chiral technologies. DSM delivers comprehensive custom
manufacturing services to the spectrum of pharmaceutical companies including
emerging pharmaceutical companies and large pharmaceutical companies from
clinical to commercial manufacturing.
Royal DSM N.V. - The
Life Sciences and Materials Sciences Company
Royal DSM N.V.
creates innovative products and services in Life Sciences and Materials
Sciences that contribute to the quality of life. DSM’s products and services
are used globally in a wide range of markets and applications, supporting a
healthier, more sustainable and more enjoyable way of life. End markets
include human and animal nutrition and health, personal care, pharmaceuticals,
automotive, coatings and paint, electrics and electronics, life protection and
housing. DSM has annual sales of almost EUR 8.8 billion and employs some
23,000 people worldwide. The company is headquartered in the Netherlands,
with locations on five continents. DSM is listed on Euronext Amsterdam. More
information: www.dsm.com
ACS Green Chemistry Institute® Pharmaceutical Roundtable
The ACS Green Chemistry Institute® Pharmaceutical Roundtable is a partnership
between the American Chemical Society’s Green Chemistry Institute and member
pharmaceutical companies dedicated to the integration of green chemistry and
green engineering in the global pharmaceutical industry. Current members
include AstraZeneca, Boehringer-Ingelheim, DSM Pharmaceutical Products, Eli
Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Inc.,
Pfizer Inc, Schering-Plough, and Wyeth. The activities of the Roundtable
reflect the joint belief that the pursuit of green chemistry and green
engineering is imperative for sustainable business and world environment. The
Roundtable focuses on four strategic priorities: informing and influencing the
research agenda; defining and delivering tools for innovation; educating
leaders; and collaborating globally. More information on the Pharmaceutical
Roundtable can be found at
www.acs.org/gcipharmaroundtable.
